ScienceDirect - Journal of Allergy and Clinical Immunology : Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome

Links shared publicly online about this topic.

  • 1,121
    total visits

ScienceDirect - Journal of Allergy and Clinical Immunology : Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome

sciencedirect.com —

ScienceDirect - Journal of Allergy and Clinical Immunology : Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome

View full resource at sciencedirect.com

Tags: Allergy and Immunology, Allergies, Vasculitis, Churg-Strauss Syndrome, Disease and Condition

  • Share

Most Recently Shared on June 3, 2010 at 5:41 pm By:

wheezemd Michael Blaiss, MD

Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome: http://bit.ly/9IU9wO

2 years ago...

Reply

Retweet

Favorite

Advertisement